AG
Therapeutic Areas
OKYO Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Urcosimod (OK-101) | Neuropathic Corneal Pain (NCP) | Phase 2 |
Leadership Team at OKYO Pharma
GC
Gabriele Cerrone
Non-Executive Chairman
RD
Robert Dempsey
Chief Executive Officer/Director
FM
Flavio Mantelli
Chief Medical Officer
PH
Pedram Hamrah
Member, Scientific Advisory Board
JS
Jay S. Pepose
Member, Scientific Advisory Board
VP
Victor Perez
Member, Scientific Advisory Board
MM
Mina Massaro Giordano
Member, Scientific Advisory Board